Attorney General Miyares announced Virginia received its first initial payment from the opioid manufacturer Janssen Pharmaceuticals. The initial payment of $67.4 million includes approximately $11 million for the state, $16 million for Virginia’s localities, and $40 million for the Opioid Abatement Authority. This settlement also requires Janssen to stop selling opioids in the United States, prevents them from promoting opioids or funding third parties that promote opioids, and prevents them from lobbying on legislation, regulations, or activities related to opioids.